« Previous
Next »
Pediatrics & Neonatology
Volume 51, Issue 1
, Pages 31-36
, February 2010
Effects of Budesonide and Fluticasone Propionate in Pediatric Asthma Patients
References
- . Inflammatory mediators of asthma: an update . Pharmacol Rev . 1998;50:515–596
- . Tumour necrosis factor-alpha: the role of this multifunctional cytokine in asthma . Immunol Cell Biol . 2001;79:132–140
- . Cytokines in asthma . Eur Respir J Suppl . 2001;34:24s–33s
- . Release of both CCR4-active and CXCR3-active chemokines during human allergic pulmonary late-phase reactions . J Allergy Clin Immunol . 2003;112:930–934
- . Enhanced generation of helper T type 1 and 2 chemokines in allergen-induced asthma . Am J Respir Crit Care Med . 2004;169:1118–1124
- . Discrepant clinical responses and blood chemokine profiles between two non-steroidal anti-inflammatory medications for children with mild persistent asthma . Pediatr Allergy Immunol . 2005;16:306–309
- Plasma TARC concentration may be a useful marker for asthmatic exacerbation in children . Eur Respir J . 2003;21:616–620
- . The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4 . J Biol Chem . 1997;272:15036–15042
- Development and cross-sectional validation of the Childhood Asthma Control Test . J Allergy Clin Immunol . 2007;119:817–825
- Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists . J Allergy Clin Immunol . 2006;117:549–556
-
Global Initiative for Asthma. Global strategy for asthma management and prevention. In: National Institutes of Health. National Heart, Lung, and Blood Institute, 2008. Available at: http://www.ginasthma.com/ [Date accessed: December 20, 2008]
- . Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics . Am Rev Respir Dis . 1990;142:832–836
-
.
Expert panel report 3: guidelines for the diagnosis and management of asthma
.
Available at: http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf
[Date accessed: December 20, 2008]
- Airway cell and cytokine changes in early asthma deterioration after inhaled corticosteroid reduction . Clin Exp Allergy . 2007;37:1189–1198
- Development of the asthma control test: a survey for assessing asthma control . J Allergy Clin Immunol . 2004;113:59–65
- . Lung function and immunopathological changes after inhaled corticosteroid therapy in asthma . Eur Respir J . 1992;5:73–79
-
.
Mechanism of action of inhaled corticosteroids in bronchial asthma: a controlled study
.
Eur Respir J
. 1994;7:421S;
[Abstract]
- . Molecular mechanisms of glucocorticoid action in asthma . Pulm Pharmacol Ther . 1997;10:3–19
- . Inhaled corticosteroids in the treatment of respiratory allergy: safety vs. efficacy . J Pediatr (Rio J) . 2006;82:S198–S205
- The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics . J Clin Invest . 2001;107:1357–1364
- . T-helper 1-related chemokines in the exacerbation of childhood asthma . Pediatr Int . 2008;50:99–102
- . The potential role of tumour necrosis factor alpha in asthma . Clin Exp Allergy . 1993;23:247–250
- . Exhaled biomarkers . Chest . 2006;130:1541–1546
- . Exhaled nitric oxide in childhood asthma: a review . Clin Exp Allergy . 2008;38:246–259
-
.
Fluticasone versus beclomethasone or budesonide for chronic asthma in adults and children
.
Cochrane Database Syst Rev
. 2007;
CD002310.
- . Fluticasone and budesonide nanosuspensions for pulmonary delivery: preparation, characterization, and pharmacokinetic studies . J Pharm Sci . 2008;97:4869–4878
PII: S1875-9572(10)60007-1
doi: 10.1016/S1875-9572(10)60007-1
© 2010 Taiwan Pediatric Association. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Pediatrics & Neonatology
Volume 51, Issue 1
, Pages 31-36
, February 2010
